Key Details
The draft Bill redesigns India’s pharmacy regulatory architecture by replacing the council-based model with a Commission-led framework that separates education, quality assurance, ethics, registration and institutional assessment into specialised bodies while introducing competency-based licensing and integrated digital regulation.
Reform Area | What Changes | Why It Matters |
|---|---|---|
Regulatory Reform | Repeals the Pharmacy Act, 1948 and establishes the National Pharmacy Commission | Modernises governance of pharmacy education and professional regulation |
Institutional Architecture | Commission with Chairperson, 15 ex-officio members, 13 part-time members and Pharmacy Advisory Council | Improves coordination between the Centre, States and professional bodies |
Autonomous Boards | Four specialised Boards for education, assessment & rating, ethics & registration, and Indian Systems of Medicine & Homoeopathy | Separates standard-setting, quality assurance and professional regulation |
National Exit Test | Introduces National Exit Test (Pharmacy) for licensure and postgraduate admissions | Establishes competency-based entry into professional practice |
Quality Assurance | Accreditation, institutional assessment, public ratings and graded regulatory actions | Strengthens accountability and educational standards |
Digital Governance | Creates a live National Register synchronised with State Registers | Improves transparency, workforce mobility and regulatory oversight |
Transition | Dissolves Pharmacy Council of India while protecting existing qualifications, registrations and approvals | Ensures continuity during regulatory transition |
Summary
Rebuilding India’s Pharmacy Regulatory Architecture
Rather than introducing incremental amendments to the Pharmacy Act, 1948, the draft legislation proposes a complete redesign of India’s pharmacy regulatory system. It replaces the existing Pharmacy Council of India with a National Pharmacy Commission (NPC) that combines national standard-setting with specialised regulatory institutions, while retaining implementation responsibilities for reconstituted State Pharmacy Councils.
The proposed framework seeks to improve quality, affordability and access to pharmacy education, strengthen professional standards, and ensure the availability of competent pharmacy professionals across modern medicine as well as Indian Systems of Medicine and Homoeopathy.
Separating Regulation into Specialised Institutions
One of the Bill’s most significant reforms is the creation of four autonomous Boards, each responsible for a distinct regulatory function:
Pharmacy Education Board (Modern System of Medicine)
Pharmacy Education Board (Indian Systems of Medicine & Homoeopathy)
Pharmacy Assessment and Rating Board
Pharmacy Ethics and Registration Board
This represents a shift away from a single regulator performing multiple functions towards a more specialised governance model that separates education, institutional quality, professional ethics and registration.
The Bill also establishes a Pharmacy Advisory Council, providing a formal mechanism for States and Union Territories to participate in national policy discussions.
Competency-Based Licensing and Digital Regulation
The draft Bill places competency assessment at the centre of professional regulation by introducing the National Exit Test (Pharmacy) as the common gateway for professional licensure and postgraduate admissions. Pharmacy graduates—including those holding recognised foreign qualifications—would be required to clear the examination before entering professional practice in India.
The Bill further proposes a live National Register of Pharmacy Professionals, digitally synchronised with State Registers to improve transparency, facilitate workforce mobility and strengthen regulatory oversight through real-time information sharing.
Quality Assurance Becomes a Continuous Process
Instead of relying primarily on approvals, the Bill introduces a broader quality assurance framework based on institutional accreditation, periodic assessment, public ratings and graded regulatory interventions. Persistent non-compliance could attract progressively stronger measures ranging from warnings and monetary penalties to reduced student intake, suspension of admissions or withdrawal of institutional recognition.
Detailed transition provisions ensure that recognised qualifications, registrations, institutional approvals, employees, assets and liabilities of the existing Pharmacy Council of India continue without disruption as the new regulatory framework is implemented.
What is the National Pharmacy Commission?
The National Pharmacy Commission (NPC) is the proposed statutory regulator that would replace the Pharmacy Council of India under the Draft National Pharmacy Commission Bill, 2026. It is designed to regulate pharmacy education, professional standards, institutional quality and registration through specialised Boards, competency-based licensing and an integrated digital regulatory framework.
Policy Relevance
Replaces India’s council-based pharmacy regulation with a Commission-led governance architecture, separating education, assessment, ethics and registration into specialised institutions.
Aligns pharmacy education with wider reforms in health professional regulation by introducing a National Exit Test as the common competency-based pathway to professional practice.
Creates a stronger quality assurance ecosystem through accreditation, institutional assessment, public ratings and risk-based regulatory interventions rather than one-time approvals.
Strengthens digital regulation by integrating National and State Registers into a synchronised platform, improving transparency, professional mobility and regulatory efficiency.
Preserves cooperative federalism by retaining State Pharmacy Councils for implementation while establishing a Pharmacy Advisory Council for structured Centre-State coordination.
Provides a carefully managed transition by protecting recognised qualifications, existing registrations, institutional approvals and ongoing academic programmes while replacing the Pharmacy Council of India.
Invites stakeholder consultation until 31 July 2026, allowing pharmacy institutions, professionals, industry bodies and State governments to shape the final legislative framework before its introduction in Parliament.
Relevant Question for Policy Stakeholders: How can the proposed National Pharmacy Commission ensure that competency-based licensing, institutional quality assurance and digital regulation improve professional standards without creating unnecessary compliance burdens for pharmacy institutions and State regulators?
Follow the Full Draft Here: Draft National Pharmacy Commission Bill, 2026